Institute for Vascular Signalling, Centre for Molecular Medicine, Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60596, Frankfurt am Main, Germany.
Pflugers Arch. 2010 May;459(6):793-806. doi: 10.1007/s00424-009-0767-7. Epub 2009 Dec 13.
Endothelial cells situated at the interface between blood and the vessel wall play a crucial role in controlling vascular tone and homeostasis, particularly in determining the expression of pro- and anti-atherosclerotic genes. Many of these effects are mediated by changes in the generation and release of the vasodilator nitric oxide (NO) in response to hemodynamic stimuli exerted on the luminal surface of endothelial cells by the streaming blood (shear stress) and the cyclic strain of the vascular wall. The endothelial NO synthase (eNOS) is activated in response to fluid shear stress and numerous agonists via cellular events such as; increased intracellular Ca(2+), interaction with substrate and co-factors, as well as adaptor and regulatory proteins, protein phosphorylation, and through shuttling between distinct sub-cellular domains. Dysregulation of these processes leads to attenuated eNOS activity and reduced NO output which is a characteristic feature of numerous patho-physiological disorders such as diabetes and atherosclerosis. This review summarizes some of the recent findings relating to the molecular events regulating eNOS activity.
内皮细胞位于血液和血管壁之间的界面上,对于控制血管张力和内稳态起着至关重要的作用,特别是在决定促动脉粥样硬化和抗动脉粥样硬化基因的表达方面。这些作用中的许多是通过对内皮细胞腔面施加的血流(剪切力)和血管壁的循环应变引起的血管舒张因子一氧化氮(NO)的生成和释放的变化来介导的。内皮型一氧化氮合酶(eNOS)在受到流体剪切力和许多激动剂的刺激后,通过细胞内事件如增加细胞内 Ca(2+)、与底物和辅助因子以及衔接蛋白和调节蛋白相互作用、蛋白磷酸化,以及通过在不同的亚细胞结构域之间穿梭而被激活。这些过程的失调导致 eNOS 活性减弱和 NO 产生减少,这是许多病理生理紊乱(如糖尿病和动脉粥样硬化)的特征。本文综述了一些与调节 eNOS 活性的分子事件相关的最新发现。
Pflugers Arch. 2009-12-13
Am J Physiol Heart Circ Physiol. 2007-8
Cardiovasc Res. 1999-8-15
Am J Physiol Heart Circ Physiol. 2007-12
Curr Atheroscler Rep. 2025-8-7
Medicina (Kaunas). 2025-5-2
Basic Clin Pharmacol Toxicol. 2025-5
Bioengineering (Basel). 2025-2-17
Int J Mol Sci. 2024-12-13
Front Cell Dev Biol. 2024-10-23
Free Radic Biol Med. 2009-10-21
EMBO Rep. 2009-10
Br J Pharmacol. 2009-6-5
Am J Physiol Lung Cell Mol Physiol. 2009-8